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TAG—Is It It?
Improving Coronary Computed
Tomography Angiography With the
Isotemporal Transluminal Contrast
Attenuation Gradient*
Andrew J. Einstein, MD, PHD
New York, New York
Can we improve on coronary computed tomography an-
giography (CCTA)? Numerous multicenter studies and
meta-analyses have found good diagnostic performance for
CCTA in the identification of significant coronary stenoses,
in comparison with a reference standard defined by percent
stenosis on invasive angiography. Like its invasive counter-
part, however, computed tomography (CT) angiography
does not assess per se the physiologic or functional signifi-
cance of a particular stenosis. Results from the FAME
(Fractional Flow Reserve versus Angiography for Multives-
sel Evaluation) and FAME II trials have demonstrated the
added benefit of physiologic information, specifically frac-
tional flow reserve (FFR), above anatomic information
alone, in guiding intervention in patients with multivessel
coronary disease undergoing intervention (1) and patients
with stable coronary disease (2). Complementing the ana-
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tomic information obtained by CCTA with physiologic
information, which can be used to better identify patients
who would or would not benefit from revascularization,
offers the potential to make CCTA a more useful tool for
the noninvasive evaluation of coronary disease.
Toward this aim, a variety of approaches have been
considered to obtain physiologic information from CT.
These methods include CT myocardial perfusion imaging;
FFR-CT, which estimates FFR from CT data by means of
modeling coronary blow flow using computational fluid
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Philips Healthcare.dynamics techniques; and several metrics deriving from the
gradient in contrast opacification along a coronary artery.
Each of these various approaches is still early in its
development, and each has advantages and disadvantages.
For example, CT perfusion was noted to increase diagnostic
accuracy over CT angiography alone in the not yet pub-
lished 16-center CORE320 study (The Coronary Artery
Evaluation using 320-row Multidetector Computed To-
mography Angiography and Myocardial Perfusion Study)
(3); however, it generally requires at least 1 additional CT
scan, with an attendant radiation and contrast burden (4).
The 17-center DeFACTO (Determination of Fractional
Flow Reserve by Anatomic Computed Tomographic An-
giography) study, although not meeting its prespecified
primary outcome goal for the level of per-patient diagnostic
accuracy, showed FFR-CT to improve diagnostic accuracy
and discrimination versus CCTA alone, with decreased
FFR as a reference standard (5). Nevertheless, FFR-CT is
tremendously computationally complex, requiring 6 hours
of time on an off-site parallel supercomputer to numerically
solve the Navier–Stokes equations describing fluid flow, and
thus is still of limited utility for patients requiring real-time
assessment. Quantification of the transluminal contrast
attenuation gradient (TAG), while presently with fewer
data to support it than CT perfusion or FFR-CT, has
particular appeal insofar as it does not require additional
radiation or contrast, or lengthy, off-site computation.
The hypothesis motivating TAG as a metric is that
contrast opacification should in theory fall off more rapidly
in the presence of a functionally significant stenosis than in
the absence of stenosis. TAG is determined using the
average contrast opacification (measured in Hounsfield
units) in a series of evenly spaced regions of interest, drawn
perpendicularly to the centerline of a coronary artery. TAG
is defined as the regression coefficient of the line fitting the
plot of average contrast opacification versus distance from
the coronary ostium, and thus reflects the rate of fall-off of
contrast opacification along a vessel.
There have been a few previous single-center studies
evaluating the TAG. Initial work by Steigner et al. (6)
demonstrated that plots of contrast opacification versus
distance are generally linear, and that TAG is of greater
magnitude in patients with stenotic lesions. This has been
followed by 3 papers from Choi, Toon, and colleagues at
Seoul National University Hospital (7–9). In the first, Choi
et al. (7) found that TAG increased consistently with
maximum stenosis severity, in regard to a reference standard
of quantitative invasive angiography, and contributed to
improved classification of coronary artery stenosis severity,
particularly in severely calcified lesions. Two subsequent
papers from this group have compared TAG with FFR,
using FFR 0.80 as a reference standard. In one (8), Choi
et al. demonstrated moderate diagnostic performance of
TAG alone, with a sensitivity of 47.5%, a specificity of
91.2%, and a significant improvement in the area under the
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added to semiquantitative classification of the degree of
stenosis on CCTA, from 0.73 to 0.81. However, addition of
TAG to CCTA did not result in a significant reclassifica-
tion improvement (8). In the other paper (9), Yoon et al.
compared TAG with FFR-CT, finding a greater area under
the receiver operating characteristic curve for FFR-CT,
although this difference was not statistically significant for
vessels with calcified plaques.
One limitation of these studies (7–9), pointed out by
Choi et al. (8), is that images were obtained using 64-
detector row CT scanners. Because of the limited cranio-
caudal coverage of 64-detector row scanners, the images
they obtain of coronary arteries are composites, comprising
approximately 4-cm segments, obtained in successive heart-
beats and stitched together. As such, opacification along a
vessel does not reflect contrast intensity at a single time,
potentially limiting the diagnostic performance of the TAG
method.
In this issue of the Journal, Wong et al. (10) assess the
diagnostic accuracy of TAG in 78 coronary arteries from 54
consecutive evaluable patients undergoing both CCTA and
invasive coronary angiography with FFR. TAG was deter-
mined from CCTA images obtained on a 320-detector row
scanner, which enables isotemporal, single-heartbeat,
whole-heart image acquisition, and FFR 0.80 was re-
garded as the reference standard for a functionally signifi-
cant stenosis. Thirty of the vessels (38%) were classified as
functionally significant. The authors noted a bootstrap-
resampled sensitivity of 77% and specificity of 74% for TAG
alone. Generalized estimating equation analysis identified
TAG and visual assessment of the degree of stenosis on
CCTA as being independently predictive of a functionally
significant stenosis, whereas integrated discrimination im-
provement index analysis suggested that TAG significantly
improves both sensitivity and specificity over degree of
stenosis alone. TAG was highly reproducible and outper-
formed the contrast opacification difference across a steno-
sis, a simpler metric also deriving from the gradient in
contrast opacification (11).
What implications do this study, and its surrounding
literature, have for CCTA practice? The study by Wong et
al. (10) further supports the potential complementary roles
of anatomic and physiologic information obtained from
CCTA scans. Its more optimistic findings, in comparison
with those in the recent papers from the Seoul group (7–9),
suggest that TAG may perform better using a scanner
enabling isotemporal coronary image acquisition.
Nevertheless, several questions remain. The study was
performed at a single expert center, with a modest sample
size, and surely needs to be more broadly validated. Initial
evaluations of diagnostic test performance are characteristi-
cally better than those achieved in real-world clinical prac-
tice, and so it remains to be seen whether TAG still
significantly complements the degree of stenosis under the
latter conditions. There are a number of reasons for thisdiscrepancy in test performance. Initial evaluations are
generally performed with more narrow and distinct spec-
trums of diseased and nondiseased patients than are en-
countered clinically, which may falsely elevate measures of
diagnostic performance (12). For example, the present study
excluded patients with branch vessel disease and distal vessel
disease. Wider adoption of and confidence in a diagnostic
test leads to patients with negative test results less frequently
undergoing subsequent evaluation, which is often more
definitive but more invasive. This change is accompanied by
a decrease in observed test specificity, because it is these very
subsequent tests that are required to establish the reference
standard diagnosis. This phenomenon of preferential selec-
tion of positive test responders for verification, caused by
early validation of a test, has been referred to as post-test
referral bias (13). Were TAG to become more established,
patients with negative (high magnitude) TAG values would
be unlikely to be referred for invasive angiography with
FFR, so true negative test results would go unidentified, and
the test specificity estimated in practice (true negatives
divided by true negatives plus false positives) would de-
crease. At the same time, false-negative test results would go
unidentified, leading to the sensitivity estimated in practice
being falsely elevated (14).
Another question remaining to answer is which func-
tional CT test—TAG, FFR-CT, CT perfusion, or some
other—is the best choice for functional assessment, and
whether this choice varies between patient populations and
clinical scenarios. For practical implementation of TAG,
more automated image processing software would need to
be developed and validated. It would not be difficult to
integrate such software with curved multiplanar reconstruc-
tion that is now standard on workstations used to read
CCTA scans, and thus to routinely determine TAG, at no
additional cost, while reading a CCTA scan. For patients
potentially benefiting further from the more sophisticated
analysis provided by FFR-CT, such as those with stenoses
of questionable significance, the option would remain to
transfer image data sets for its performance on an outside
supercomputer; and for patients for whom stress myocardial
perfusion assessment is likely to provide additional benefi-
cial information, stress testing could be added to the CT
protocol. Ultimately, benefit should be assessed, as in the
FAME trials evaluating FFR, in terms of improvement in
patient-important outcomes. At the present time, however,
the value of each of these CT technologies and their
comparative effectiveness remain unclear. Thus, perhaps we
can improve on CCTA with the addition of physiologic
data, but the path forward will require considerably more
investigation.
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